Magnetocardiography ( MCG), a technique that measures the weak magnetic field generated by human electrophysiological activities, provides non-invasive, ionizing-radiation-free functional information.Compared with traditional structural imaging techniques, MCG can capture functional changes in the early stages of diseases, making it particularly suitable for early screening and disease progression assessment. In recent years,rapid advancements in quantum magnetic sensors, magnetic shielding, and active compensation technologies have enabled MCG to overcome the limitations of low-temperature superconductivity and magnetically shielded rooms gradually, developing in the direction of greater convenience and lower cost. However, despite its significant potential in clinical applications such as chest pain triage, coronary heart disease screening, and myocardial ischemia assessment, the clinical translation of MCG still faces challenges including insufficient specificity and lack of standardization. Furthermore, variations in equipment and signal processing methods lead to low comparability among research findings. This article reviews the development history and current application status of MCG technology, synthesizes the research progress of our team over the past three years, discusses the bottlenecks in applying MCG across different clinical settings, and proposes that future research should focus on areas such as physical mechanisms, feature interpretability, establishing quantitative relationships between diseases, and improving clinical diagnostic specificity. These efforts aim to promote the standardization of MCG, and advance its research and application in the fields of cardiology, neurology, oncology, and traditional Chinese medicine.
Objective To investigate the application value of transesophageal echocardiography ( TEE) in diagnosing left atrial appendage thrombus (LAAT) among patients with atrial fibrillation (AF), and to analyze the impact of echocardiographic parameters and clinical factors on the diagnosis of LAAT by TEE. Methods Clinical data of 326 AF patients who had undergone TEE examination were retrospectively analyzed. Patients were divided into LAAT positive group ( n = 52) and negative group ( n = 274) according to TEE results. Patients' general information, AF type and duration, echocardiographic parameters, and TEE findings were recorded. Univariate analysis was performed. ROC curves were used to evaluate the predictive efficacy of left atrial appendage peak flow velocity (LAAV) and left atrial appendage area (LAAA) for LAAT. Independent influencing factors for LAAT in AF patients were identified via Logistic regression analysis. The Hosmer-Lemeshow test and decision curve analysis were employed to assess the goodness-of-fit and clinical utility of the predictive model. Results TEE detected LAAT in 52 (16. 0%) AF patients. Compared with the LAAT negative group, patients in the LAAT positive group were older, had longer AF duration, higher CHA2DS2-VASc scores, larger left atrial diameter (LAD) and LAAA,lower LAAV, and a higher proportion of persistent or permanent AF (all P<0. 05). For predicting thrombus, the area under the curve (AUC) was 0. 893 for LAAV, with an optimal cutoff value of 25. 6 cm / s, sensitivity of 82. 7%, and specificity of 84. 3%. The AUC value for LAAA was 0. 812, with an optimal cutoff value of 5. 2 cm2,sensitivity of 76. 9%, and specificity of 75. 5%. The combined prediction of LAAV and LAAA increased the AUC value to 0. 921, which was significantly higher than the predictive efficacy of LAAV or LAAA used alone (both P<0. 05). Logistic regression analysis identified longer AF duration (OR = 1. 089), decreased LAAV (OR = 0. 876),and larger LAAA (OR = 1. 626) as independent risk factors for LAAT (all P<0. 05). The Hosmer-Lemeshow test indicated good model fit ( P = 0. 587 ), and decision curve analysis confirmed its good clinical utility.Conclusion TEE is an effective tool for diagnosing LAAT in AF patients. Longer AF duration, decreased LAAV,and larger LAAA are independent risk factors for LAAT formation. The combined application of LAAV and LAAA could significantly enhance the predictive value for LAAT, and may serve as an important screening indicator inTEE examinations.